Cargando…
Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) caused by liver lipid dysregulation is linked to obesity. Somatostatin (SST) and its analogs have been used to treat pediatric hypothalamic obesity. However, the application of such drugs for the treatment of NAFLD has not been evaluated. OBJECTI...
Autores principales: | Li, Mao, Ye, Ting, Wang, Xiao-Xia, Li, Xian, Qiang, Ou, Yu, Tao, Tang, Cheng-Wei, Liu, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803296/ https://www.ncbi.nlm.nih.gov/pubmed/27002331 http://dx.doi.org/10.1371/journal.pone.0152085 |
Ejemplares similares
-
Effects of octreotide on hepatic glycogenesis in rats with high fat diet-induced obesity
por: Wang, Xiao-Xia, et al.
Publicado: (2017) -
Fructus Xanthii Attenuates Hepatic Steatosis in Rats Fed on High-Fat Diet
por: Li, Xiumin, et al.
Publicado: (2013) -
Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet-Induced Obesity
por: Woo, Shih-Lung, et al.
Publicado: (2014) -
Helminthostachys zeylanica alleviates hepatic steatosis and insulin resistance in diet-induced obese mice
por: Chang, Ting-Chen, et al.
Publicado: (2019) -
Transplantation of Gut Microbiota From High-Fat-Diet-Tolerant Cynomolgus Monkeys Alleviates Hyperlipidemia and Hepatic Steatosis in Rats
por: Gao, Jiang-Mei, et al.
Publicado: (2022)